Emzotamig
Based on 1 Customer Validation
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF). Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 97.35%
- CAS. Nr.: 3037572-57-6
- Molecular Weight:124.59 kDa
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle TNF Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Isotype
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Species Reactivity
Human
IC50 & Target
TNFRSF17 & NCR1
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Anwendung
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized BCMA/TNFRSF17 Protein, Human (HEK293, HY-P70827) can bind Emzotamig. The ED50 for this effect is 8.653 ng/mL. -
Immobilized NKp46/NCR1 Protein, Human (HEK293, HY-P77810) can bind Emzotamig. The ED50 for this effect is 172.2 ng/mL.
Chemical Information
-
CAS. Nr. 3037572-57-6
-
Appearance Liquid
-
Molecular Weight 124.59 kDa
-
Color Colorless to off-white
-
SMILES
N/A
-
Versand
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (269 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)